Mexican Pharmaceuticals & Biotech Potentially Undervalued Companies

BioCryst Pharmaceuticals

Market Cap: Mex$1.4b

A biotechnology company, develops oral small-molecule and injectable protein therapeutics to treat rare diseases.

Fortrea Holdings

Market Cap: Mex$1.8b

A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.

Mirum Pharmaceuticals

Market Cap: Mex$2.1b

A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.

Daiichi Sankyo Company

Market Cap: Mex$6.0t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

United Therapeutics

Market Cap: Mex$12.8b

A biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Inovio Pharmaceuticals

Market Cap: Mex$64.5m

A biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases.

Otsuka Holdings

Market Cap: Mex$3.6t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Agios Pharmaceuticals

Market Cap: Mex$2.0b

A biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.

PeptiDream

Market Cap: Mex$278.1b

A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.

ICON

Market Cap: Mex$16.0b

A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.

Takeda Pharmaceutical

Market Cap: Mex$6.6t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.

WuXi Biologics (Cayman)

Market Cap: Mex$61.6b

An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.

Laboratorios Farmaceuticos Rovi

Market Cap: Mex$2.6b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

Waters

Market Cap: Mex$19.2b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

Genmab

Market Cap: Mex$82.0b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

Bausch Health Companies

Market Cap: Mex$1.7b

Operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally.

Ultragenyx Pharmaceutical

Market Cap: Mex$3.9b

A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.

Merck KGaA

Market Cap: Mex$63.7b

Operates as a science and technology company in Germany.

Johnson & Johnson

Market Cap: Mex$370.2b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

Novo Nordisk

Market Cap: Mex$1.9t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

GSK

Market Cap: Mex$54.6b

Engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Amicus Therapeutics

Market Cap: Mex$3.2b

A biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.

BioNTech

Market Cap: Mex$23.8b

A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.

Novo Nordisk

Market Cap: Mex$1.9t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

Charles River Laboratories International

Market Cap: Mex$9.0b

Charles River Laboratories International, Inc.

InflaRx

Market Cap: Mex$93.0m

A clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States.

Gerresheimer

Market Cap: Mex$3.6b

Manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally.

Mettler-Toledo International

Market Cap: Mex$21.8b

Manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally.

AbbVie

Market Cap: Mex$312.8b

A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.

Ono Pharmaceutical

Market Cap: Mex$1.3t

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

Thermo Fisher Scientific

Market Cap: Mex$166.5b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.

BioMarin Pharmaceutical

Market Cap: Mex$11.5b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Amgen

Market Cap: Mex$152.0b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Roche Holding

Market Cap: Mex$204.7b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

GSK

Market Cap: Mex$54.6b

Engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Sanofi

Market Cap: Mex$112.1b

A healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.